New pill tested as potential lifeline for Tough-to-Treat blood cancers
NCT ID NCT03162536
Summary
This study is testing a new oral medication called nemtabrutinib for people with advanced B-cell blood cancers that have come back or stopped responding to other treatments. The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. It is for adults with specific types of leukemia and lymphoma who have already tried at least two other therapies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Colorado Blood Cancer Institute ( Site 0225)
Denver, Colorado, 80218, United States
-
Duke Cancer Center ( Site 0067)
Durham, North Carolina, 27710, United States
-
Mayo Clinic - Rochester ( Site 0138)
Rochester, Minnesota, 58905, United States
-
Mayo Clinic Hospital ( Site 0140)
Scottsdale, Arizona, 85259, United States
-
Tennessee Oncology, PLLC ( Site 0020)
Nashville, Tennessee, 37203, United States
-
The Ohio State University Wexner Medical Center ( Site 0056)
Columbus, Ohio, 43210, United States
-
UCLA Hematology & Oncology ( Site 0017)
Los Angeles, California, 90095, United States
-
UT Southwestern Medical Center ( Site 0116)
Dallas, Texas, 75390-8562, United States
-
University of Michigan ( Site 0018)
Ann Arbor, Michigan, 48109, United States
-
University of Utah, Huntsman Cancer Institute ( Site 0122)
Salt Lake City, Utah, 84112, United States
Conditions
Explore the condition pages connected to this study.